XML 31 R20.htm IDEA: XBRL DOCUMENT v3.24.3
Fair Value Measurements (Tables)
9 Months Ended
Nov. 02, 2024
Fair Value Disclosures [Abstract]  
Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis

The following table presents financial instruments that are measured at fair value on a recurring basis at November 2, 2024, February 3, 2024 and October 28, 2023:

 

 

 

Fair Value Measurements

 

(In thousands)

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

As of November 2, 2024

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents - money market mutual funds

 

$

65,529

 

 

$

0

 

 

$

0

 

 

$

65,529

 

Marketable securities - mutual funds that fund
    deferred compensation

 

 

13,866

 

 

 

0

 

 

 

0

 

 

 

13,866

 

Total

 

$

79,395

 

 

$

0

 

 

$

0

 

 

$

79,395

 

As of February 3, 2024

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents - money market mutual funds

 

$

91,733

 

 

$

0

 

 

$

0

 

 

$

91,733

 

Marketable securities - mutual funds that fund
    deferred compensation

 

 

12,247

 

 

 

 

 

 

 

 

 

12,247

 

Total

 

$

103,980

 

 

$

0

 

 

$

0

 

 

$

103,980

 

As of October 28, 2023

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents - money market mutual funds

 

$

53,275

 

 

$

0

 

 

$

0

 

 

$

53,275

 

Marketable securities - mutual funds that fund
    deferred compensation

 

 

11,226

 

 

 

 

 

 

 

 

 

11,226

 

Total

 

$

64,501

 

 

$

0

 

 

$

0

 

 

$

64,501

 

Schedule Of Deferred Compensation Plan Liabilities And Related Marketable Securities

The following tables present the balances and activity of the Company’s deferred compensation plan liabilities and related Marketable Securities:

 

(In thousands)

 

November 2, 2024

 

 

February 3, 2024

 

 

October 28, 2023

 

Deferred compensation plan current liabilities

 

$

193

 

 

$

114

 

 

$

1,619

 

Deferred compensation plan long-term liabilities

 

 

13,449

 

 

 

11,639

 

 

 

9,770

 

Total deferred compensation plan liabilities

 

$

13,642

 

 

$

11,753

 

 

$

11,389

 

Marketable securities - mutual funds that fund deferred compensation

 

$

13,866

 

 

$

12,247

 

 

$

11,226

 

 

(In thousands)

 

Thirteen
Weeks Ended
 November 2, 2024

 

 

Thirteen
Weeks Ended
 October 28, 2023

 

 

Thirty-nine
Weeks Ended
 November 2, 2024

 

 

Thirty-nine
Weeks Ended
 October 28, 2023

 

Deferred compensation liabilities

 

 

 

 

 

 

 

 

 

 

 

 

   Employer contributions, net

 

$

83

 

 

$

62

 

 

$

234

 

 

$

233

 

   Investment earnings (losses)

 

 

632

 

 

 

(1,031

)

 

 

1,214

 

 

 

(375

)

Marketable Securities

 

 

 

 

 

 

 

 

 

 

 

 

Mark-to-market (gains) losses (1)

 

 

(585

)

 

 

993

 

 

 

(1,169

)

 

 

376

 

Net deferred compensation expense

 

$

130

 

 

$

24

 

 

$

279

 

 

$

234

 

(1) Included in the mark-to-market activity related to equity securities still held at quarter-end, we recognized an unrealized gain of $568,000 and an unrealized loss of $919,000 for the thirteen weeks ended November 2, 2024 and October 28, 2023, respectively, and unrealized gains of $1,118,000 and $141,000 for the thirty-nine weeks ended November 2, 2024 and October 28, 2023, respectively.